These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9870013)

  • 1. Should patients with implantable cardioverter-defibrillators be allowed to drive? Observations in 291 patients from a single center over an 11-year period.
    Trappe HJ; Wenzlaff P; Grellman G
    J Interv Card Electrophysiol; 1998 Jun; 2(2):193-201. PubMed ID: 9870013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inappropriate implantable cardioverter defibrillator shocks-incidence, effect, and implications for driver licensing.
    Watanabe E; Okajima K; Shimane A; Ozawa T; Manaka T; Morishima I; Asai T; Takagi M; Honda T; Kasai A; Fujii E; Yamashiro K; Kohno R; Abe H; Noda T; Kurita T; Watanabe S; Ohmori H; Nitta T; Aizawa Y; Kiyono K; Okumura K
    J Interv Card Electrophysiol; 2017 Sep; 49(3):271-280. PubMed ID: 28730420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Automobile driving and implantable defibrillators].
    Lerecouvreux M; Aït Saïd M; Paziaud O; Perrier E; Carlioz R; Lavergne T; Guize L; Le Heuzey JY
    Arch Mal Coeur Vaiss; 2005 Apr; 98(4):288-93. PubMed ID: 15881843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resumption of driving after life-threatening ventricular tachyarrhythmia.
    Akiyama T; Powell JL; Mitchell LB; Ehlert FA; Baessler C;
    N Engl J Med; 2001 Aug; 345(6):391-7. PubMed ID: 11496849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Driving restrictions for arrhythmia patients--with special reference to the implantable cardioverter/defibrillator].
    Lüderitz B; Jung W
    Z Kardiol; 1996; 85 Suppl 6():115-21. PubMed ID: 9064955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syncope in patients with an implantable cardioverter-defibrillator: incidence, prediction and implications for driving restrictions.
    Bänsch D; Brunn J; Castrucci M; Weber M; Gietzen F; Borggrefe M; Breithardt G; Block M
    J Am Coll Cardiol; 1998 Mar; 31(3):608-15. PubMed ID: 9502643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor vehicle accidents in patients with an implantable cardioverter-defibrillator.
    Curtis AB; Conti JB; Tucker KJ; Kubilis PS; Reilly RE; Woodard DA
    J Am Coll Cardiol; 1995 Jul; 26(1):180-4. PubMed ID: 7797749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy: implications for antiarrhythmic therapy and driving restrictions. CARE Group.
    Freedberg NA; Hill JN; Fogel RI; Prystowsky EN;
    J Am Coll Cardiol; 2001 Jun; 37(7):1910-5. PubMed ID: 11401131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is it safe to allow patients with implantable cardioverter-defibrillators to drive? Learnings from a single center experience.
    Curnis A; Mascioli G; Bontempi L; Cerini M; Bignotti T; Bonetti G; Dei Cas L
    J Cardiovasc Med (Hagerstown); 2008 Dec; 9(12):1241-5. PubMed ID: 19001931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
    Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience.
    Conte G; Sieira J; Ciconte G; de Asmundis C; Chierchia GB; Baltogiannis G; Di Giovanni G; La Meir M; Wellens F; Czapla J; Wauters K; Levinstein M; Saitoh Y; Irfan G; Julià J; Pappaert G; Brugada P
    J Am Coll Cardiol; 2015 Mar; 65(9):879-88. PubMed ID: 25744005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.
    Elliott PM; Sharma S; Varnava A; Poloniecki J; Rowland E; McKenna WJ
    J Am Coll Cardiol; 1999 May; 33(6):1596-601. PubMed ID: 10334430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Implantable cardioverter-defibrillators in the prevention of sudden cardiac death].
    Kozák M; Krivan L; Semrád B
    Vnitr Lek; 2001 Jun; 47(6):361-70. PubMed ID: 11494881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The implantable defibrillator and return to operation of vehicles study.
    Mylotte D; Sheahan RG; Nolan PG; Neylon MA; McArdle B; Constant O; Diffley A; Keane D; Nash PJ; Crowley J; Daly K
    Europace; 2013 Feb; 15(2):212-8. PubMed ID: 22968849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%.
    Grimm W; Hoffmann J Jü; Müller HH; Maisch B
    J Am Coll Cardiol; 2002 Mar; 39(5):780-7. PubMed ID: 11869841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effect of implantable cardioverter defibrillator replacements: when should you resume driving after an implantable cardioverter defibrillator replacement?
    Kawata H; Noda T; Kurita T; Yamagata K; Yamada Y; Okamura H; Satomi K; Shimizu W; Suyama K; Aihara N; Isobe M; Kamakura S
    Circ J; 2010 Nov; 74(11):2301-7. PubMed ID: 20877125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of outcome in patients with implantable transvenous cardioverter defibrillators.
    Tebbenjohanns J; Schumacher B; Jung W; Korte T; Pfeiffer D; Manz M; Lüderitz B
    Am Heart J; 1994 Apr; 127(4 Pt 2):1086-9. PubMed ID: 8160585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time Course of Subsequent Shocks After Initial Implantable Cardioverter-Defibrillator Discharge and Implications for Driving Restrictions.
    Merchant FM; Hoskins MH; Benser ME; Roberts G; Bastek AN; Knezevic A; Huang Y; Langberg JJ; Leon AR; El-Chami MF
    JAMA Cardiol; 2016 May; 1(2):181-8. PubMed ID: 27437889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.